用 JAK 抑制剂成功治疗杜必鲁单抗诱发的银屑病皮炎/关节炎和特应性皮炎：病例报告和文献综述

The journal of allergy and clinical immunology. Global Pub Date : 2024-08-05 DOI:10.1016/j.jacig.2024.100323

Misuzu Tsunoda MD , Takeya Adachi MD, PhD , Yuuri Nakajima MD , Yoshihiro Yatomi MD , Tomoko Shimizu MD, PhD , Katsuki Nakasute MD

{"title":"用 JAK 抑制剂成功治疗杜必鲁单抗诱发的银屑病皮炎/关节炎和特应性皮炎：病例报告和文献综述","authors":"Misuzu Tsunoda MD , Takeya Adachi MD, PhD , Yuuri Nakajima MD , Yoshihiro Yatomi MD , Tomoko Shimizu MD, PhD , Katsuki Nakasute MD","doi":"10.1016/j.jacig.2024.100323","DOIUrl":null,"url":null,"abstract":"<div><p>Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.</p></div>","PeriodicalId":75041,"journal":{"name":"The journal of allergy and clinical immunology. Global","volume":"3 4","pages":"Article 100323"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277282932400119X/pdfft?md5=e2cefb2bbc0ec8490f41e39229f8fe37&pid=1-s2.0-S277282932400119X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review\",\"authors\":\"Misuzu Tsunoda MD , Takeya Adachi MD, PhD , Yuuri Nakajima MD , Yoshihiro Yatomi MD , Tomoko Shimizu MD, PhD , Katsuki Nakasute MD\",\"doi\":\"10.1016/j.jacig.2024.100323\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.</p></div>\",\"PeriodicalId\":75041,\"journal\":{\"name\":\"The journal of allergy and clinical immunology. Global\",\"volume\":\"3 4\",\"pages\":\"Article 100323\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S277282932400119X/pdfft?md5=e2cefb2bbc0ec8490f41e39229f8fe37&pid=1-s2.0-S277282932400119X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The journal of allergy and clinical immunology. Global\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S277282932400119X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of allergy and clinical immunology. Global","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S277282932400119X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

一位特应性皮炎患者因使用杜匹单抗引发的银屑病皮炎和关节炎，在使用达帕替尼后得到了有效控制，这凸显了使用Janus激酶抑制剂治疗生物疗法副作用的可能性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review

Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The journal of allergy and clinical immunology. Global Immunology, Allergology and Rheumatology

CiteScore

0.70

自引率

0.00%

发文量

审稿时长

92 days